CTSH
Basic information
Region (hg38): 15:78921058-78949574
Previous symbols: [ "CPSB" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTSH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 16 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 16 | 6 | 4 |
Variants in CTSH
This is a list of pathogenic ClinVar variants found in the CTSH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-78922189-G-A | CTSH-related disorder | Likely benign (Nov 09, 2022) | ||
15-78922192-C-T | not specified | Uncertain significance (May 23, 2024) | ||
15-78922996-T-A | not specified | Uncertain significance (Sep 22, 2023) | ||
15-78923025-T-G | not specified | Uncertain significance (Dec 07, 2021) | ||
15-78923062-T-C | not specified | Uncertain significance (Mar 19, 2024) | ||
15-78925349-G-C | not specified | Likely benign (May 14, 2024) | ||
15-78925355-T-C | not specified | Uncertain significance (Dec 21, 2021) | ||
15-78925362-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
15-78927712-C-T | Likely benign (Jul 11, 2018) | |||
15-78927771-C-A | not specified | Uncertain significance (Aug 21, 2023) | ||
15-78929435-C-G | not specified | Uncertain significance (Apr 15, 2024) | ||
15-78931491-C-T | not specified | Uncertain significance (Dec 23, 2022) | ||
15-78931509-GGAA-G | Likely benign (Jul 31, 2018) | |||
15-78932375-GGACA-G | Variant of unknown significance | Uncertain significance (Aug 08, 2013) | ||
15-78932389-C-T | not specified | Uncertain significance (May 23, 2023) | ||
15-78932401-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
15-78935075-G-A | not specified | Uncertain significance (Jan 07, 2022) | ||
15-78935684-G-A | not specified | Uncertain significance (Nov 29, 2021) | ||
15-78935730-C-G | not specified | Uncertain significance (Oct 18, 2021) | ||
15-78937337-A-G | Benign (Jun 12, 2018) | |||
15-78937338-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
15-78937341-T-C | not specified | Uncertain significance (Jan 08, 2024) | ||
15-78937349-G-A | CTSH-related disorder | Likely benign (Feb 14, 2023) | ||
15-78937358-C-T | Likely benign (Nov 08, 2018) | |||
15-78937403-C-T | Benign (Dec 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CTSH | protein_coding | protein_coding | ENST00000220166 | 12 | 28517 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.25e-8 | 0.804 | 125610 | 0 | 138 | 125748 | 0.000549 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.535 | 170 | 191 | 0.891 | 0.0000104 | 2188 |
Missense in Polyphen | 60 | 78.507 | 0.76426 | 893 | ||
Synonymous | -0.880 | 82 | 72.5 | 1.13 | 0.00000438 | 593 |
Loss of Function | 1.52 | 16 | 24.0 | 0.666 | 0.00000119 | 260 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00122 | 0.00122 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.00315 | 0.00316 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000309 | 0.000308 |
Middle Eastern | 0.00315 | 0.00316 |
South Asian | 0.000490 | 0.000490 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Important for the overall degradation of proteins in lysosomes.;
- Pathway
- Lysosome - Homo sapiens (human);Apoptosis - Homo sapiens (human);Neutrophil degranulation;Surfactant metabolism;Metabolism of proteins;MHC class II antigen presentation;Innate Immune System;Immune System;Adaptive Immune System
(Consensus)
Recessive Scores
- pRec
- 0.324
Intolerance Scores
- loftool
- 0.448
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.61
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.808
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ctsh
- Phenotype
- respiratory system phenotype; normal phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- metanephros development;T cell mediated cytotoxicity;adaptive immune response;immune response-regulating signaling pathway;proteolysis;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of cell population proliferation;positive regulation of gene expression;positive regulation of epithelial cell migration;neuropeptide catabolic process;bradykinin catabolic process;positive regulation of peptidase activity;antigen processing and presentation;positive regulation of cell migration;zymogen activation;protein destabilization;response to retinoic acid;membrane protein proteolysis;negative regulation of apoptotic process;surfactant homeostasis;neutrophil degranulation;cellular protein metabolic process;positive regulation of angiogenesis;proteolysis involved in cellular protein catabolic process;dichotomous subdivision of terminal units involved in lung branching;ERK1 and ERK2 cascade;cellular response to thyroid hormone stimulus;positive regulation of apoptotic signaling pathway
- Cellular component
- extracellular region;extracellular space;lysosome;cytosol;secretory granule lumen;cytoplasmic ribonucleoprotein granule;intracellular membrane-bounded organelle;extracellular exosome;alveolar lamellar body;multivesicular body lumen;tertiary granule lumen;ficolin-1-rich granule lumen
- Molecular function
- endopeptidase activity;aminopeptidase activity;cysteine-type endopeptidase activity;serine-type endopeptidase activity;protein binding;peptidase activity;cysteine-type peptidase activity;cysteine-type endopeptidase activator activity involved in apoptotic process;HLA-A specific activating MHC class I receptor activity;thyroid hormone binding